455 related articles for article (PubMed ID: 17292727)
1. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
[TBL] [Abstract][Full Text] [Related]
2. Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
Jacobson PB; von Geldern TW; Ohman L; Osterland M; Wang J; Zinker B; Wilcox D; Nguyen PT; Mika A; Fung S; Fey T; Goos-Nilsson A; Grynfarb M; Barkhem T; Marsh K; Beno DW; Nga-Nguyen B; Kym PR; Link JT; Tu N; Edgerton DS; Cherrington A; Efendic S; Lane BC; Opgenorth TJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):191-200. PubMed ID: 15784656
[TBL] [Abstract][Full Text] [Related]
3. Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats.
Berthiaume N; Carlson CJ; Rondinone CM; Zinker BA
Metabolism; 2005 Nov; 54(11):1515-23. PubMed ID: 16253642
[TBL] [Abstract][Full Text] [Related]
4. Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production.
Edgerton DS; Jacobson PB; Opgenorth TJ; Zinker B; Beno D; von Geldern T; Ohman L; Scott M; Neal D; Cherrington AD
Metabolism; 2006 Sep; 55(9):1255-62. PubMed ID: 16919547
[TBL] [Abstract][Full Text] [Related]
5. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
6. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
Li L; Yang GY
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice.
Liang Y; Osborne MC; Monia BP; Bhanot S; Watts LM; She P; DeCarlo SO; Chen X; Demarest K
Metabolism; 2005 Jul; 54(7):848-55. PubMed ID: 15988691
[TBL] [Abstract][Full Text] [Related]
8. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
[TBL] [Abstract][Full Text] [Related]
9. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
van den Hoek AM; Heijboer AC; Voshol PJ; Havekes LM; Romijn JA; Corssmit EP; Pijl H
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E238-45. PubMed ID: 16940471
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise.
Király MA; Bates HE; Yue JT; Goche-Montes D; Fediuc S; Park E; Matthews SG; Vranic M; Riddell MC
Metabolism; 2007 Jun; 56(6):732-44. PubMed ID: 17512304
[TBL] [Abstract][Full Text] [Related]
11. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
12. Effect of sodium salicylate on oxidative stress and insulin resistance induced by free fatty acids.
He B; Zhao S; Zhang W; Li Y; Han P
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):49-53. PubMed ID: 20133229
[TBL] [Abstract][Full Text] [Related]
13. Long-term intracerebroventricular infusion of insulin, but not glucose, modulates body weight and hepatic insulin sensitivity by modifying the hypothalamic insulin signaling pathway in type 2 diabetic rats.
Park S; Hong SM; Ahn IS
Neuroendocrinology; 2009; 89(4):387-99. PubMed ID: 19176946
[TBL] [Abstract][Full Text] [Related]
14. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
Broca C; Breil V; Cruciani-Guglielmacci C; Manteghetti M; Rouault C; Derouet M; Rizkalla S; Pau B; Petit P; Ribes G; Ktorza A; Gross R; Reach G; Taouis M
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E463-71. PubMed ID: 15082420
[TBL] [Abstract][Full Text] [Related]
15. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
Lam TK; van de Werve G; Giacca A
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
[TBL] [Abstract][Full Text] [Related]
16. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
Laager R; Ninnis R; Keller U
J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
[TBL] [Abstract][Full Text] [Related]
18. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
Ohara S; Komatsu R; Matsuyama T
Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
[TBL] [Abstract][Full Text] [Related]
19. In vivo insulin resistance during nonlethal hypermetabolic sepsis.
Lang CH; Dobrescu C
Circ Shock; 1989 Jun; 28(2):165-78. PubMed ID: 2661048
[TBL] [Abstract][Full Text] [Related]
20. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats.
Hsieh PS; Tai YH; Loh CH; Shih KC; Cheng WT; Chu CH
Metabolism; 2005 Feb; 54(2):157-64. PubMed ID: 15690308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]